Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peripheral artery disease
MedTech
Abbott posts positive, longer-term data for its Esprit BTK stent
In patients with chronic limb-threatening ischemia, the drug-eluting scaffold cut the number of repeat procedures by about half in two years.
Conor Hale
Nov 5, 2024 11:00am
R3 Vascular raises $87M for bioresorbable, below-the-knee stent
May 17, 2024 12:31pm
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
J&J adds Shockwave to its cardio collection with $13.1B deal
Apr 5, 2024 11:00am
Cagent nets $30M for serrated balloon catheter
Feb 21, 2024 12:00pm
Abbott's drug-laden, resorbable implant clears leg artery study
Oct 27, 2023 10:38am
